Litcius/Paper detail

Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes

Mohamed Sayed Zaazouee, Aboalmagd Hamdallah, Sara Kamel Helmy, Elfatih A. Hasabo, Ahmed Kamal Sayed, Mohamed Ibrahim Gbreel, Aya Abd Elmegeed, Hala Aladwan, Alaa Ahmed Elshanbary, Walid Abdel‐Aziz, Israa Mohamed Elshahawy, Shehab Rabie, Sherouk Elkady, Ahmed Ali, Khaled Mohamed Ragab, Anas Zakarya Nourelden

2022Diabetes & Metabolic Syndrome Clinical Research & Reviews43 citationsDOI

Topics & Concepts

SemaglutideMedicineSitagliptinLiraglutidePlaceboAdverse effectEmpagliflozinDulaglutideCochrane LibraryInternal medicineMeta-analysisTripterygium wilfordiiRandomized controlled trialSitagliptin PhosphateType 2 diabetesDiabetes mellitusEndocrinologyAlternative medicinePathologyDiabetes Treatment and ManagementBariatric Surgery and OutcomesHyperglycemia and glycemic control in critically ill and hospitalized patients
Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes | Litcius